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Near-infrared Spectroscopy for Evaluation of Peripheral Vascular
Disease. A Systematic Review of Literature
M. Vardi1* and A. Nini2
1Internal Medicine, Carmel Medical Center, 7 Michal St., Haifa 34362, Israel, and 2Intensive Care Unit,
Sheba Medical Center, 2 Sheba Rd., Tel Hashomer 52661, Israel
Objectives. To assess near-infrared spectroscopy (NIRS) as a method for the diagnosis and evaluation of peripheral vas-
cular disease.
Search strategy. MEDLINE and CENTRAL were searched with a search protocol presented below. Handsearching
through reference lists of the retrieved articles and reviews was conducted.
Main results. 224 and 57 abstracts from MEDLINE and CENTRAL respectively were retrieved from which 21 studies
were selected. NIRS was evaluated for the diagnosis and severity evaluation in patients with peripheral vascular disease. Its
parameters were shown to reflect the clinical status of patients, with good correlation to existing methods.
Conclusions. Currently NIRS technology can serve as an adjunct method for the diagnosis and evaluation of patients with
peripheral vascular disease.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Peripheral vascular disease (PVD) is a common dis-
ease of the elderly, resulting in compromise of blood
flow to the lower limbs. Several techniques are
currently being used to aid the diagnosis and severity
assessment of patients with PVD. These include an-
kle-brachial index, segmental limb pressure and
plethysmography, Duplex ultrasound, multidetector
computed tomography,1 and magnetic resonance
spectroscopy or imaging. These techniques assess
blood supply but not oxygen and nutrient transport,
essential for limb vitality and functionality. Transcuta-
neous oximetry (TcpO2) and laser Doppler fluximetry
measure local oxygen tension at the surface of the skin
and total skin perfusion, respectively, and serve as ad-
juncts in the assessment of PVD severity.
Near infrared spectroscopy is a technology in
which oxygen saturation of haemoglobin is measured
using near infrared (NIR) light. The percentage of
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by passing specific wavelengths of light through
blood and measuring its absorption. Since the
amounts of light absorbed by oxygenated haemoglo-
bin and by deoxygenated haemoglobin are different,
the relative concentration of oxygenated haemoglobin
can be determined. Near-infrared spectroscopy has
been used since the eighties, mostly for the assess-
ment of cerebral circulation. Animal experiments
have indicated that skeletal muscle oxygen consump-
tion (V02) is proportional to blood flow.
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The aim of this systematic review of literature is to
assess the clinical efficacy of NIRS for the diagnosis
and evaluation of peripheral vascular disease.
Methods
Criteria for considering studies for this review
Prospective clinical trials were sought, in which NIRS
was used for the diagnosis and severity evaluation of
patients with peripheral vascular disease from any eti-
ology, and of any age and gender. Studies designed to
evaluate a therapeutic intervention were excluded.lar Surgery. Published by Elsevier Ltd. All rights reserved.
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ered. We searched MEDLINE and CENTRAL (until
June 2007) with the following search strategy: ((‘‘Spec-
troscopy,Near-Infrared’’[MeSH])OR (NIR*) OR (tissue
spectroscopy*) OR (tissue oxygen*) OR (tissue hypox*)
OR (muscle spectroscopy) OR (muscle oxygen*) OR
(muscle hypox*) OR (muscle oxygen consumption)
OR (‘‘Oxygen Consumption/analysis’’[MeSH])) AND
((‘‘Peripheral Vascular Diseases’’ [MeSH]) OR (PVD*)
OR (Peripheral arterial Disease) OR (PAOD)OR (leg is-
chemia) OR (‘‘Intermittent Claudication’’ [MeSH]). We
tried to identify additional studies by searching the ref-
erence lists of relevant trials and reviews identified.
Two independent reviewers scanned the titles and
abstracts of the studies retrieved. Full articles were
retrieved for further assessment when appropriate.
Doubts and differences of opinion were resolved by
open discussion.
Results
224 and 57 abstracts from MEDLINE and CENTRAL,
respectively, were retrieved. 29 studies were further
assessed. 25 trials met the inclusion criteria specified
above. Four studies were excluded. One study re-
ported a different technology for tissue oxygen mea-
surements, and one reported on pulmonary oxygen
uptake. Two used NIRS alongside other modalities
for the assessment of different interventions [Fig. 1].
NIRS for the diagnosis of PVD
The first study aimed to assess whether VO2 was
reduced in patients suffering from intermittent claudi-
cation was conducted by Cheatle et al.3 NIRS was em-
ployed on the calf muscles of 17 patients and 21
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-1 assessment of pulmonary 
oxygen uptake
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Fig. 1. Flow chart for the search strategy and reasons for
exclusion.controls, while oxygen consumption was measured
during and after a tourniquet-induced ischemia. The
authors found a significant difference in resting oxy-
gen consumption between claudicants and controls.
However, there was a broad overlap between the
groups. Correlation between VO2 and ankle-brachial
index (ABI) was reported to be poor. Median time to
reach 95% maximal level of saturated haemoglobin
(measured during post-obstructive hyperemia) was
40 seconds in claudicants compared to 20 seconds in
controls, again with a broad overlap between the
groups. McCully et al.4 compared the rate of oxygen
desaturation and resaturation during and after exer-
cise of calf muscles of people with PVD, with that of
healthy young as well as older subjects. Oxygen desa-
turation during an exercise test was near-maximal in
the PVD group compared to healthy subjects. The
investigators found that the rate of oxygen resatura-
tion after exercise was a reproducible measurement,
with a good correlation between this parameter and
the ankle-brachial pressure index (r2¼ .63, p< 0.01).
However, their report included only 8 patients and
26 controls. In a subsequent report from this group
on a larger cohort (n¼ 117),5 clinical evidence of
PVD was compared to NIRS half time of recovery to
baseline parameters (T50), reflecting tissue oxygena-
tion. Half time to recovery values for participants
with PVD was significantly longer. The sensitivity
and specificity of two threshold values were assessed
(40 and 50 seconds) to estimate the usefulness of NIRS
as a screening tool for PVD. Sensitivity and specificity
ranged from 50 to 80% for both thresholds. Lee et al.6
reported 11 claudicants and 12 healthy controls as-
sessed with NIRS at rest, while standing, and during
and post exercise. During the postexercise recovery
period, all but one of the subjects without claudication
showed an increase in oxygenation index (log differ-
ence of red reflectance from infrared reflectance). In
the patients with claudication, the oxygenation index
in three limbs decreased in the immediate postexer-
cise recovery period, while it increased slowly in six
limbs and rapidly in two limbs. Harrison et al.7 inves-
tigated NIRS potential to diagnose PVD, during and
after standard treadmill exercise in 19 patients and
nine healthy controls. T50 was significantly longer
for the patients than controls. No threshold was re-
ported. Cassavola et al.8 investigated the application
of NIRS for the diagnosis of PVD in four patients.
They found that T50 was in the range of seconds in
healthy legs, and minutes for legs affected by periph-
eral vascular disease. No threshold for this distinction
was advised. Another report from Kooijman et al.9
evaluating 11 patients and 15 healthy controls, dem-
onstrated that during rest VO2 was similar for theEur J Vasc Endovasc Surg Vol 35, January 2008
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walking exercise it declined significantly more in
claudicants. In addition the report showed that clau-
dicants exhibited a lower resaturation rate of oxyhae-
moglobin (HbO2) and longer recovery times, after
both walking and arterial occlusion. These parameters
were correlated to ABI measurements. Seifalian et al.10
evaluated the changes in NIRS in 14 patients with
intermittent claudication and 10 controls, pre- and
postexercise. There was a significant ( p< 0.001)
difference in the degree and rate of HbO2 deoxygen-
ation between claudicants and controls. The period
of recovery of HbO2 postexercise was also signifi-
cantly slower in claudicants. Comerota et al.11
explored the diagnostic sensitivity of quantified mus-
cle saturation (StO2) for PVD, and the correlation
between StO2 dynamics and ABI, on 14 patients
with PVD and 35 controls. They found that peak exer-
cise StO2, absolute change between baseline and peak
StO2, percent change between baseline and peak StO2,
half time to recovery of StO2 and full time of recovery
of StO2 (T100) were all significantly different between
PVD patients and controls. A significant correlation
between half time and full time of recovery of StO2
to ABI was found (r¼.65, p< 0.001, r¼.48,
p¼ 0.035, respectively). They report a cut-point for
T50 maximizing sensitivity without loosing specificity
of >70 seconds (89% and 75% respectively). For T100
a cut-point of 165 seconds yielded a sensitivity and
specificity of 88% and 81% respectively. Wolf et al.12
found significant differences between patients with
documented PVD, patients with risk factor for PVD,
and healthy subjects, with respect to oxygen con-
sumption, venous oxygen saturation, as well as
changes in oxyhaemoglobin, deoxyhaemoglobin and
total haemoglobin after venous occlusions of 60 and
180 seconds. Some of these indicators were significant
for differentiating PVD patients from patients with
risk factors, some between patients with risk factors and
healthy volunteers, and some between PVD patients
and healthy volunteers. ABI was correlated with
SVO2, haemoglobin flow, oxy- and total-haemoglobin
concentration differences after 60 seconds of venous
occlusion. Mapping areas of reduced oxygenation
and flow was also possible. Watanabe et al.13 evalu-
ated NIRS in 62 limbs from patients with peripheral
occlusive disease and reported highly significant cor-
relation in the recovery time between the ABI and
StO2, Oxy- and deoxy-haemoglobin. The recovery
time for NIRS parameters were shorter than for ABI,
reflecting the different physiological events monitored
by these two modalities. Ubbink et al.,14 in a study
with 45 patients and 20 controls, reported StO2 as be-
ing able to discriminate controls from claudicants inEur J Vasc Endovasc Surg Vol 35, January 2008response to treadmill exercise but not during rest.
The post exercise StO2 as well as the decrease in
StO2 during exercise correlated with lower ABI.
Post occlusive reactive hyperemia (PORH) is one of
the well-known clinical tests for lower limb ischaemia.
Kragelj et al.15 usedNIRSduring aPORHtest on 24PVD
patients and 18 healthy volunteers and compared it to
TcpO2 readings and baseline ABI. Recovery time pa-
rameters (including the time interval from the release
of the cuff until the initial values from NIRS recording
are reached; the time to reach 95% of the maximal sig-
nals) and reoxygenation rates (the maximal change in
the signal after the release of the cuff expressed as the
percentage of the signal change during arterial occlu-
sion, and the maximal change in signals during the re-
active hyperemia) all differed significantly between
PVD patients and controls. Some of these parameters
also correlated well with baseline ABI and TcpO2
values. Interestingly, diabetic patients had a delayed
hyperemic response and lower reoxygenation rates
than non diabetics, with a broad overlap between the
two groups. Jarm et al.16 reported the use of three non-
invasive methods for the distinction between three
healthy volunteers and patients with PVD: TcPO2,
near-infrared spectroscopy, and LDF measurements
during PORH. Results of all three methods provided
distinction between healthy volunteers and patients.
NIRS and LDF demonstrated the difference between
healthy volunteers and patients more clearly than
TcPO2. The dynamics of the PORH response detected
by NIRS and LDF proved to be a better indicator of pe-
ripheral vascular disease than the amplitude of re-
sponses. Cheng et al.17 utilized StO2 changes during
and post PORH test for the assessment of PVD in nine
patients and 10 controls. They assessed [Dt]phase-i as
the time required for 80% change in StO2 in phase i of
the four phases of the PORH test (accumulation, ische-
mia, reperfusion and dispersion), and [DStO2]phase-i
as the StO2 change rate at the middle value of StO2 in
phase i. Three parameters were found to qualify as in-
dicators of PVD: [Dt]reperfusion, [DStO2]reperfusion,
and [DStO2]dispersionwith a p-value< 0.001 for thedif-
ferentiation between the control and PVD groups. As
a diagnostic tool, a subject may have higher risk for
PVD if [Dt]reperfusion >40 seconds and [DStO2]reper-
fusion <50%/minute, and [DStO2]dispersion <5%/
minute. The sensitivity and specificity were between
80 and 100%.
NIRS for evaluation of the severity of PVD
NIRS as a method for assessing PVD severity was the
subject of four trials. Komiyama et al.18 studied the
changes in tissue oxygenation in the calf muscle in
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tion in the calf during a treadmill test. Three distinc-
tive patterns of oxygenated and deoxygenated
haemoglobin ratios were observed. The findings cor-
related with disease severity as assessed by the ability
to walk for more than five minutes, the mean maxi-
mum walking distance and the mean ankle-brachial
pressure index at rest. They were referred to as types
0, 1 and 2. A subsequent report19 evaluated NIRS with
treadmill walking as a method for assessing PVD in
diabetics. All type 0 legs completed a five minutes
treadmill walking test, while none of the type 2 legs
were able to do so. These authors also reported the
ability to evaluate absolute muscle saturation with
spatially resolved spectroscopy (SRS).20 This measure
differentiated normal controls from three groups of
claudicants according to clinical status.
NIRS for the evaluation of patients with PVD and
diabetes mellitus
Kragelj et al.15 reported a post-hoc analysis in which
non-significant delayed recovery times and lower re-
oxygenation rates after PORH in diabetics with PVD
compared to non-diabetics with PVD were observed.
Komiyama et al.19 evaluated NIRS with treadmill
walking as a method for assessing PVD in diabetics,
compared with resting ABI, on 208 symptomatic
legs from 153 patients. They concluded that recovery
time measured with NIRS is a better marker than rest-
ing ABI for the diagnosis and assessment of severity
of claudication in diabetics. Mohler et al.22 recently
published a study aimed at determining whether
NIRS hemodynamic measurements are perturbed in
patients with diabetes before the development of
clinically significant PVD. 25 healthy controls, 17
diabetics, 13 claudicants and 19 claudicants with
concomitant diabetes were enrolled. Blood volume
expansion did not differ between controls and dia-
betics, but was increased in PVD patients. PVD
patients with diabetes had an attenuated blood
volume response compared to PVD only patients.
Diabetes had no effect on T50 or percentage of deoxy-
genation, unlike the presence of PVD, which signifi-
cantly increased both values. These results are
argued to reflect a decrease in the vasodilatation
capacity of patients with diabetes, presumably due
to endothelial dysfunction.
Combining NIRS with other modalities
Other modalities for assessing patients suffering from
PVD exist. In 2001, Kemp et al.24 evaluated thesimultaneous use of NIRS and magnetic resonance
spectroscopy (MRS) during an exercise test. Both
NIRS and MRS signals fell during exercise and then
recovered. Claudicants showed faster and greater de-
oxygenation during exercise, despite reduced oxygen
consumption, and slower resaturation afterwards.
This supports the idea that oxidative metabolism im-
pairment in peripheral arterial disease is a result of
impaired oxygen delivery.
Reproducibility
McCully et al.4 found the rate of oxygen resaturation
after exercise is a reproducible measurement. Ubbink
et al.14 studied twenty healthy volunteers to assess the
reproducibility of NIRS. Calf measurements had good
reproducibility (intraclass correlation coefficient of
0.91 before treadmill and 0.90 after treadmill) but those
performed on the dorsum of the foot were less reliable.
New NIRS based technology
New NIRS based technology has emerged in recent
years to expand its clinical and experimental utility.
Three reports demonstrated these novel approaches
on patientswith peripheral arterial disease. Komiyama
et al. have used spatially resolved spectroscopy, which
is based on intensity changes at multiple spacing, and
provides an absolute tissue oxygen saturation index
in addition to changes in oxygenation.20 Wolf et al.12
used NIRS to demonstrate maps and spatial distribu-
tion of haemoglobin flow, concentration and oxygena-
tion, enabling identification of local irregularities in
haemoglobin flow, concentration and oxygenation. Yu
et al.25 have used near-infrared diffuse correlation spec-
troscopy (DCS), a technique for continuous noninva-
sive measurement of relative blood flow in deep
tissues, and diffuse reflectance spectroscopy (DRS), to
measure blood flow and oxygenation in cuffed and ex-
ercising human muscle. These techniques may be ap-
plicable in the future but are currently not clinically
useful in the setting of PVD.
Assessment of parameters for evaluation of patients with
peripheral arterial disease
Manyparameterswere evaluated as being efficient indi-
cators for PVD existence and severity. The parameters
are mostly derivatives of changes in tissue oxy- and
deoxyhaemoglobin saturation, during rest, venous oc-
clusion, muscle ischemia, exercise challenge, and recov-
eryphases. Standard exercise protocols, post obstructive
reactive hyperemia test, as well as modified techniques
to induce muscle hypoxia were employed [Table 1].
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Parameter Study Outcome
Oxygen consumption Cheatle et al.3 Resting VO2 significantly different between claudicants and controls with a broad
overlap between the groups
Kooijman et al.9 Resting VO2 not significantly different between their groups VO2 differed
significantly one minute after a standard walking exercise
Wolf et al.12 VO2 after venous occlusion differed between patients and controls.
Saturation recovery times Cheatle et al.3 median time to reach 95 per cent maximal saturated haemoglobin level was 40
seconds in claudicants compared to 20 seconds in controls, with a broad overlap
between the groups
Harrison et al.7 T50 e best indicator for differentiating PVD patients from controls, after exercise test
Cassavola et al.8 T50 e in the range of seconds in healthy legs, and minutes for legs with PVD.
McCully et al.5 Time to recovery values for PVD patients- significantly longer
Kooijman et al.9 Higher recovery times of HbO2, after walking and after arterial occlusion.
Seifalian et al.10 Recovery of HbO2 postexercise significantly slower among claudicants.
Comerota et al.11 Half time and full time to recovery of StO2 significantly different between PVD
patients and controls
Wantanabe et al.13 Good correlation in recovery time of StO2 and ABI, although shorter time for StO2
was noted.
Ubbink et al.14 Good correlation between StO2 during and after exercise and post-exercise ABI.
Saturation recovery times
during PORH test
Kragelj et al.15 Time interval between the release of cuff until the initial values from NIRS recording
were reached, and the time to reach 95% of the maximal signals, differed with
statistical significance between PVD patients and controls.
Jarm et al.16 Time intervals for recovery to initial values, maximum values and half of the initial
values e the best indicators of disease.
Cheng et al.17 Time required for 80% change in StO2 during PORH reperfusion phase- significantly
different between patients and controls.
StO2 kinteics under low
work rates*
Bauer et al.32 StO2 responses were similar under these conditions, yet the time course of muscle
oxygen desaturation was prolonged in the PVD group, reflecting slower dynamic
increase in oxygen consumption.
Rate of resaturation after
exercise
McCully et al.4 Rate of oxygen resaturation after exercise is a reproducible measurement, and
significantly slower in PVD patients compared to controls
Kooijman et al.9 Resaturation rate of O2Hb lower after walking after arterial occlusion.
Kragelj et al.15 Reoxygenation rates significantly different between groups
O2 desaturation rate and
time
McCully et al4 Oxygen desaturation during an exercise test to be near-maximal in the PVD group
compared to healthy subjects.




Comerota et al.11 Absolute change between baseline and peak StO2 and percent change between
baseline and peak StO2 e differentiating controls from patients.
Wolf et al.12 Changes in oxyhaemoglobin, deoxyhaemoglobin and total haemoglobin after venous
occlusion of 60 and 180 second- significantly different between groups.
Quantitative measures of
tissue saturation:
Comerota et al.11 Peak exercise StO2- a significant marker for PVD
* In low work rates blood flow response is presumably similar in healthy and occluded limbs.Safety
Only one report11 employing NIRS technology on
patients with PVD referred to safety issue. They
reported no adverse events.
Discussion and Conclusion
Several methods exist to diagnose and assess the sever-
ity of peripheral vascular disease. The most common of
all is measurement of ankle-brachial pressure index.26
This method lacks the ability to measure blood flows.
Doppler ultrasound can be used for this purpose,27
but previous reports havedemonstrated that femoral ar-
tery flow is not sufficiently reliable to assess tissue ische-
mia.28 Venous occlusion plethysmography indirectlyEur J Vasc Endovasc Surg Vol 35, January 2008quantifies and detects vascular abnormalities based on
volume change in the leg.27,29 Magnetic resonance spec-
troscopy has been applied to evaluate PVD,30 but its
clinical use is limited due to high costs and lack of
availability. Doppler fluximetry and transcutaneous ox-
ygen tension measurement are also available for micro-
circulatory evaluation, but should be interpreted
cautiously in patients with PVD.31 Near-infrared spec-
troscopy monitors the key pathophysiological determi-
nant of PVD, i.e. oxygen delivery to tissues themselves.
It is designed to allow an objective assessment ofmuscle
bloodflowandoxygenation level,which gives rise to as-
sessment ofmismatch between oxygen demand and de-
livery to tissue. Therefore, information yielded by NIRS
is a valuable measure of PVD.
In this systematic review we have summarized re-
sults from 21 prospective clinical trials, assessing the
73Evaluation of Peripheral Vascular Diseaseapplication of NIRS for the evaluation of PVD. No gold
standard for this evaluation is available, as the clinical
presentation is aderivative of a combination of flow, tis-
sue oxygenation, oxygen extraction and utilization. It
seems from the reports presented above that NIRS is
a promising evolving technique for this purpose, en-
compassing the ability to reflect tissue dynamics.
Many parameters extracted by NIRS can be retrieved
as indicators for PVD presence, severity, and response
to treatment. Indeed, many parameters were evaluated
over the years, a reflection of the search for the best in-
dicators for clinical purposes. It seems that the best re-
portedparameters to this date are a reflection of oxygen
consumption and tissue post-hypoxia resaturation
times or rates. These parameters mostly correlated
well with ankle-brachial index. Trying to summarize
the effectiveness of NIRS in this clinical setting in
a meta-analysis is not statistically nor clinically sound,
and therefore it remains to be determined how many
patients with PVD requiring treatment would have
been missed without the more traditional diagnostic
modalities, or on the other hand without NIRS. NIRS
has not yet gained widespread use as a tool in PVD di-
agnosis. Therefore, issues of efficiency and cost of the
technique have not been addressed in the works re-
viewed. However, NIRS is a simple, easy to learn, pain-
less and complication-free technique. Its utilization is
still awaiting refinement.
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